These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9616339)

  • 1. Long-term survival effect of metoprolol in dilated cardiomyopathy. The SPIC (Italian Multicentre Cardiomyopathy Study) Group.
    Di Lenarda A; De Maria R; Gavazzi A; Gregori D; Parolini M; Sinagra G; Salvatore L; Longaro F; Bernobich E; Camerini F
    Heart; 1998 Apr; 79(4):337-44. PubMed ID: 9616339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metoprolol in dilated cardiomyopathy: is it possible to identify factors predictive of improvement? The Heart Muscle Disease Study Group.
    DiLenarda A; Gregori D; Sinagra G; Lardieri G; Perkan A; Pinamonti B; Salvatore L; Secoli G; Zecchin M; Camerini F
    J Card Fail; 1996 Jun; 2(2):87-102. PubMed ID: 8798110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
    Hoshikawa E; Matsumura Y; Kubo T; Okawa M; Yamasaki N; Kitaoka H; Furuno T; Takata J; Doi YL
    Am J Cardiol; 2011 Apr; 107(7):1065-70. PubMed ID: 21296328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metoprolol-induced functional benefit in dilated cardiomyopathy is sustained over four years and favorably influences outcome.
    De Maria R; Di Lenarda A; Gavazzi A; Porcu M; Sinagra G; Parolini M;
    Ital Heart J; 2001 Feb; 2(2):130-8. PubMed ID: 11256541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group.
    Waagstein F; Bristow MR; Swedberg K; Camerini F; Fowler MB; Silver MA; Gilbert EM; Johnson MR; Goss FG; Hjalmarson A
    Lancet; 1993 Dec; 342(8885):1441-6. PubMed ID: 7902479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dilated cardiomyopathy: a new natural history? The experience of the Italian Multicenter Cardiomyopathy Study (SPIC)].
    Gavazzi A; De Maria R; Porcu M; Beretta L; Casazza F; Castelli G; Luvini M; Parodi O; Recalcati F; Renosto G
    G Ital Cardiol; 1995 Sep; 25(9):1109-25. PubMed ID: 8529848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Beta blocking agents in the treatment of dilated cardiomyopathy: review of the literature and clinical experience with 67 patients].
    Sinagra G; Perkan A; Di Lenarda A; Lardieri G; Pinamonti B; Mestroni L; Miani D; Camerini F
    G Ital Cardiol; 1992 Aug; 22(8):969-89. PubMed ID: 1362167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
    Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G; Fornaro A; Ciaccheri M; Dolara A; Troiani V; Tomberli B; Olivotto I; Gensini GF
    Circ Heart Fail; 2013 Sep; 6(5):913-21. PubMed ID: 23888044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibitors and beta-blockers in long-term treatment of dilated cardiomyopathy.
    Regitz-Zagrosek V; Leuchs B; Krülls-Münch J; Fleck E
    Am Heart J; 1995 Apr; 129(4):754-61. PubMed ID: 7900628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-year follow-up of patients randomised in the metoprolol in dilated cardiomyopathy trial. The Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group.
    Lancet; 1998 Apr; 351(9110):1180-1. PubMed ID: 9643698
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years.
    Merlo M; Pivetta A; Pinamonti B; Stolfo D; Zecchin M; Barbati G; Di Lenarda A; Sinagra G
    Eur J Heart Fail; 2014 Mar; 16(3):317-24. PubMed ID: 24464640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of beta-blockers in the treatment of cardiomyopathy and ischaemic heart failure.
    Hjalmarson A; Waagstein F
    Drugs; 1994; 47 Suppl 4():31-9; discussion 39-40. PubMed ID: 7523060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired cardiac adrenergic innervation assessed by MIBG imaging as a predictor of treatment response in childhood dilated cardiomyopathy.
    Acar P; Merlet P; Iserin L; Bonnet D; Sidi D; Syrota A; Kachaner J
    Heart; 2001 Jun; 85(6):692-6. PubMed ID: 11359754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing mortality in dilated cardiomyopathy. The Heart Muscle Disease Study Group.
    Di Lenarda A; Secoli G; Perkan A; Gregori D; Lardieri G; Pinamonti B; Sinagra G; Zecchin M; Camerini F
    Br Heart J; 1994 Dec; 72(6 Suppl):S46-51. PubMed ID: 7873326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reductions in muscle sympathetic nerve activity after long-term metoprolol for dilated cardiomyopathy: preliminary observations.
    Rahman MA; Hara K; Daly PA; Wigle ED; Floras JS
    Br Heart J; 1995 Oct; 74(4):431-6. PubMed ID: 7488460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More favourable haemodynamic effects from metoprolol than from captopril in patients with dilated cardiomyopathy.
    Jansson K; Karlberg KE; Nylander E; Karlsson E; Nyquist O; Dahlström U
    Eur Heart J; 1997 Jul; 18(7):1115-21. PubMed ID: 9243145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with "SCD-HeFT criteria?".
    Zecchin M; Merlo M; Pivetta A; Barbati G; Lutman C; Gregori D; Serdoz LV; Bardari S; Magnani S; Di Lenarda A; Proclemer A; Sinagra G
    Am J Cardiol; 2012 Mar; 109(5):729-35. PubMed ID: 22176998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: a multi-institutional experience.
    Shaddy RE; Tani LY; Gidding SS; Pahl E; Orsmond GS; Gilbert EM; Lemes V
    J Heart Lung Transplant; 1999 Mar; 18(3):269-74. PubMed ID: 10328154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The circulating renin-angiotensin system during treatment with metoprolol or captopril in patients with heart failure due to non-ischaemic dilated cardiomyopathy.
    Jansson K; Dahlström U; Karlberg BE; Karlsson E; Nylander E; Nyquist O; Karlberg KE
    J Intern Med; 1999 May; 245(5):435-43. PubMed ID: 10363743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.